Abbott India Ltd

Abbott India Ltd

ABBOTINDIA

 30,587.38
 118.18
0.39%
Healthcare
 0.00
(%)1D
Updated: 12 Sep 2025, 03:31:27 pm IST
Stock Score
Open Price
 30,729.35
Prev. Close
 30,469.20
 30,521.35
Day Low
 30,841.11
Day High

 24,976.17
52 Week Low
 36,694.84
52 Week High

Quick Bite

Price To Earnings Ratio

45.95

Sector PE

68.61

PB Ratio

15.46

Sector PB

6.06

EPS

665.62

Dividend Yield

1.55

Today's Volume

6.425 K

5 Day Avg. Volume

11.209 K

PEG Ratio

2.59

Market Cap.

₹ 66,190.00 Cr.

About Abbott India Ltd

Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company's products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.

Abbott India Ltd Share Price

Abbott India Limited is an Indian pharmaceutical company. The company has a range of diagnostics, medical devices, nutritional products and branded generics. It offers products and solutions for various therapeutic areas such as women's and #x27 health, gastroenterology, central nervous system, metabolic, multidisciplinary, vaccines and consumer health. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (abortion and IVF), Duphalac (disease), Digene (antacid), Prothiaden (pain and depression), Influvac (flu prevention), Creon (pancreatic insufficiency), Cremalax (failure), Pankreoflat (indigestion) and Duvadilan (late labor). It offers a variety of products under brand names such as Similac, PediaSure, Pedialyte, EleCare, Ensure and Glucerna.

Abbott India Ltd FAQs

How to Buy Abbott India Ltd Share?

up
To purchase Abbott India Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Abbott India Ltd (ticker symbol: ABBOTINDIA) on the trading platform provided by your broker and purchase the shares.

What's Abbott India Ltd share price today?

up
The stock price of Abbott India Ltd as of 13 Sep 2025 is ₹30,587.38

What is the Market Cap of Abbott India Ltd?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 13 Sep 2025, Abbott India Ltd (ticker symbol: ABBOTINDIA) has a market capitalisation of approximately ₹6,61,90,00,00,000.00

What is the PE and PB ratio of Abbott India Ltd?

up
Abbott India Ltd Ltd's price-to-book ratio as of 13 Sep 2025 is 15.46, reflecting the market's valuation compared to its asset value. As of 13 Sep 2025, the trailing twelve months P/E (price-to-earnings) ratio is 45.95, indicating the market values the company at around ₹45.95 for every ₹1 of earnings

What is the 52 Week High and Low of Abbott India Ltd Share?

up
Abbott India Ltd Ltd (ABBOTINDIA) hit its 52-week high at ₹36,694.84, and its 52-week low at ₹24,976.17.
Begin your investment journey today
Login/Register
Start Now